These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17178794)

  • 41. Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess.
    Jutte PC; Rutgers SR; Van Altena R; Uges DR; Van Horn JR
    Int J Tuberc Lung Dis; 2004 Nov; 8(11):1368-72. PubMed ID: 15581207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo.
    Veziris N; Truffot-Pernot C; Aubry A; Jarlier V; Lounis N
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3117-22. PubMed ID: 14506018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
    Rustomjee R; Lienhardt C; Kanyok T; Davies GR; Levin J; Mthiyane T; Reddy C; Sturm AW; Sirgel FA; Allen J; Coleman DJ; Fourie B; Mitchison DA;
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):128-38. PubMed ID: 18230244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
    Zhang J; Guo M; Huang ZX; Bao R; Yu Q; Dai M; Wang X; Rao Y
    Chin Med J (Engl); 2019 Sep; 132(17):2089-2095. PubMed ID: 31425356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.
    Seifart HI; Parkin DP; Donald PR
    Pediatr Infect Dis J; 1991 Nov; 10(11):827-31. PubMed ID: 1749695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
    Lanoix JP; Betoudji F; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2005 Oct; 26(4):298-303. PubMed ID: 16154726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
    Battini S; Mannava MKC; Nangia A
    J Pharm Sci; 2018 Jun; 107(6):1667-1679. PubMed ID: 29462633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis.
    Wang JY; Wang JT; Tsai TH; Hsu CL; Yu CJ; Hsueh PR; Lee LN; Yang PC
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):65-71. PubMed ID: 20003697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis.
    Zimhony O; Cox JS; Welch JT; Vilchèze C; Jacobs WR
    Nat Med; 2000 Sep; 6(9):1043-7. PubMed ID: 10973326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Aug; 50(34):733-5. PubMed ID: 11787580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
    Lenaerts AJ; Hoff D; Aly S; Ehlers S; Andries K; Cantarero L; Orme IM; Basaraba RJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3338-45. PubMed ID: 17517834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis.
    Rustomjee R; Diacon AH; Allen J; Venter A; Reddy C; Patientia RF; Mthiyane TC; De Marez T; van Heeswijk R; Kerstens R; Koul A; De Beule K; Donald PR; McNeeley DF
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2831-5. PubMed ID: 18505852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci).
    Auclair B; Mikota SK; Peloquin CA; Aguilar R; Maslow JN
    J Zoo Wildl Med; 2002 Sep; 33(3):193-203. PubMed ID: 12462485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
    Palanduz A; Gültekin D; Erdem E; Kayaalp N
    Ann Trop Paediatr; 2003 Mar; 23(1):47-50. PubMed ID: 12648324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.